This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Annadasu Ankamanayudu: Innovator in Pharmaceutical Chemistry
Introduction: Annadasu Ankamanayudu, based in Hyderabad, Telangana, is a notable inventor in the pharmaceutical field. His contributions to the development and improvement of chemical processes have significantly impacted the industry. With a focus on innovative solutions, Ankamanayudu has secured recognition for his unique inventions.
Latest Patents: Ankamanayudu holds one patent titled "Process for the preparation of Cabozantinib and its pharmaceutically acceptable salts thereof." This invention pertains to an enhanced method for synthesizing the compound N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, represented by a specific structural formula. This advancement showcases his dedication to improving pharmaceutical practices.
Career Highlights: He is associated with Natco Pharma Limited, a renowned company specializing in the development of high-quality pharmaceutical products. His work at Natco Pharma has allowed him to contribute to numerous innovative projects that aim to enhance medication efficacy and patient care.
Collaborations: Throughout his career, Ankamanayudu has collaborated with esteemed colleagues such as Kompella Amala and Gampa Venugopala Krishna. These partnerships have facilitated the exchange of ideas and further propelled advancements in their respective fields.
Conclusion: Annadasu Ankamanayudu stands out as an inventor whose contributions have significantly influenced the pharmaceutical industry. With a commitment to innovation and collaboration, he continues to pave the way for new discoveries and advancements in medicine. His work illustrates the importance of inventive processes in enhancing pharmaceutical preparations for better healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
